2020–2021 BCSC Basic and Clinical Science Course™
13 Refractive Surgery
Chapter 9: Accommodative and Nonaccommodative Treatment of Presbyopia
Nonaccommodative Treatment of Presbyopia
As discussed in Chapter 7, CK is a nonablative, collagen-shrinking procedure approved for the correction of low levels of hyperopia (+0.75 to +3.25 D). This procedure has been approved by the US Food and Drug Administration (FDA) for the treatment of presbyopia in individuals with hyperopic or emmetropic vision.
Excerpted from BCSC 2020-2021 series: Section 13 - Refractive Surgery. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.